Nuvectra Corporation

Nuvectra is a neuromodulation medical device company focused on the development and commercialization of our neurostimulation technology platform for the treatment of various disorders through stimulation of tissues associated with the nervous system. The Company's neurostimulation technology platform has the capability to provide treatment to patients in several established neurostimulation markets, including spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, and other emerging neurostimulation markets. Nuvectra's Algovita SCS system, or Algovita, is the first application of the Company's stimulation technology platform and is indicated for the treatment of chronic pain of the trunk and limbs.

Company Growth (employees)
Type
Public
HQ
Plano, US
Founded
2016
Size (employees)
89 (est)
Nuvectra Corporation was founded in 2016 and is headquartered in Plano, US

Nuvectra Corporation Office Locations

Nuvectra Corporation has an office in Plano
Plano, US (HQ)
1100 5830 Granite Pkwy

Nuvectra Corporation Data and Metrics

Nuvectra Corporation Financial Metrics

Nuvectra Corporation's revenue was reported to be $5 m in Q1, 2017
USD

Revenue (Q1, 2017)

5 m

Gross profit (Q1, 2017)

2.6 m

Gross profit margin (Q1, 2017), %

52%

Net income (Q1, 2017)

(13.1 m)

EBIT (Q1, 2017)

(12.5 m)

Market capitalization (21-Sep-2017)

125.6 m

Cash (31-Mar-2017)

48.1 m
Nuvectra Corporation's current market capitalization is $125.6 m.
USDFY, 2015FY, 2016

Revenue

5.2 m12.5 m

Revenue growth, %

139%

Cost of goods sold

3.4 m6.4 m

Gross profit

1.9 m6.1 m
USDQ1, 2017Q2, 2017Q3, 2016Q1, 2017

Revenue

2.1 m2.6 m3.8 m5 m

Cost of goods sold

1.1 m1.3 m1.6 m2.4 m

Gross profit

1 m1.3 m2.1 m2.6 m

Gross profit Margin, %

49%51%57%52%
USDFY, 2015FY, 2016

Cash

202 k63.7 m

Accounts Receivable

4.2 m

Inventories

24 k5.2 m

Current Assets

764 k72.6 m
USDQ1, 2017Q2, 2017Q3, 2016Q1, 2017

Cash

90.3 m83.5 m75.6 m48.1 m

Inventories

4 m

Current Assets

92.1 m87.1 m79.7 m56.7 m

PP&E

5.2 m5.5 m6.6 m6.5 m
USDFY, 2015FY, 2016

Net Income

(24.4 m)(38.4 m)

Cash From Operating Activities

(23.4 m)(25.8 m)

Purchases of PP&E

(529 k)(4 m)

Cash From Investing Activities

(529 k)(4 m)
USDQ1, 2017Q2, 2017Q3, 2016Q1, 2017

Net Income

(7.1 m)(8.8 m)(9.5 m)(13.1 m)

Inventories

4 m

Accounts Payable

5.5 m5.8 m8.4 m5.9 m
USDY, 2017

Revenue/Employee

56.6 k

Financial Leverage

1.4 x
Show all financial metrics

Nuvectra Corporation Operating Metrics

Nuvectra Corporation's Patent Applications was reported to be 132 in FY, 2016
FY, 2016

Trademarks

5

Trademarks (foreign)

17

Trademarks Pending

31

Patent Applications

132
Show all operating metrics

Nuvectra Corporation Market Value History

Nuvectra Corporation Revenue Breakdown

Traffic Overview of Nuvectra Corporation

Nuvectra Corporation Company Life and Culture

You may also be interested in